A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions

NCT00865852 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Metformin HCl 750 mg Extender Release tablets, single dose
DRUG: GLUCOPHAGE® XR 750 mg tablets, single dose

Sponsor

Actavis Inc.